Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

In utero exposure to Azathioprine in autoimmune disease. Where do we stand?

Belizna C, Meroni PL, Shoenfeld Y, Devreese K, Aliotaj-Reig J, Esteve-Valverde E, Chighizola C, Pregnolato F, Cohen H, Fassot C, Mattera PM, Peretti P, Levy A, Bernard L, Saiet M, Lagarce L, Briet M, Rivière M, Pellier I, Gascoin G, Rakotonjanahary J, Borghi MO, Stojanovich L, Djokovic A, Stanisavljevic N, Bromley R, Amoura EE, Buisson NB, Sala TP, Kelchtermans H, Makatsariya A, Bidsatze V, Khizroeva J, Latino JO, Udry S, Henrion D, Loufrani L, Guihot AL, Muchardt C, Hasan M, Ungeheur MN, Voswinkel J, Damian L, Pabinger I, Gebhart J, Pedrera RL, Tervaert JWC, Tincani A, Andreoli L.

Autoimmun Rev. 2020 Mar 30:102525. doi: 10.1016/j.autrev.2020.102525. [Epub ahead of print] Review.

PMID:
32240856
2.

Nuclear Activation Function 2 Estrogen Receptor α Attenuates Arterial and Renal Alterations Due to Aging and Hypertension in Female Mice.

Guivarc'h E, Favre J, Guihot AL, Vessières E, Grimaud L, Proux C, Rivron J, Barbelivien A, Fassot C, Briet M, Lenfant F, Fontaine C, Loufrani L, Arnal JF, Henrion D.

J Am Heart Assoc. 2020 Mar 3;9(5):e013895. doi: 10.1161/JAHA.119.013895. Epub 2020 Feb 27.

3.

Do storage solutions protect endothelial function of arterialized vein graft in an experimental rat model?

Fouquet O, Blossier JD, Dang Van S, Robert P, Barbelivien A, Pinaud F, Binuani P, Eid M, Henrion D, Baufreton C, Loufrani L.

J Cardiothorac Surg. 2020 Feb 10;15(1):34. doi: 10.1186/s13019-020-1077-6.

4.

Painless local pressure application to test microvascular reactivity to ischemia.

Henni S, Hersant J, Loufrani L, Duval G, Humeau-Heurtier A; SIMS Group, Riou J, Abraham P; SOCOS Group.

Microvasc Res. 2019 Mar;122:13-21. doi: 10.1016/j.mvr.2018.10.013. Epub 2018 Nov 3.

PMID:
30399363
5.

Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome.

Urbanski G, Caillon A, Poli C, Kauffenstein G, Begorre MA, Loufrani L, Henrion D, Belizna C.

PLoS One. 2018 Nov 6;13(11):e0206814. doi: 10.1371/journal.pone.0206814. eCollection 2018.

6.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL.

Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Review.

PMID:
30316994
7.

Predominant Role of Nuclear Versus Membrane Estrogen Receptor α in Arterial Protection: Implications for Estrogen Receptor α Modulation in Cardiovascular Prevention/Safety.

Guivarc'h E, Buscato M, Guihot AL, Favre J, Vessières E, Grimaud L, Wakim J, Melhem NJ, Zahreddine R, Adlanmerini M, Loufrani L, Knauf C, Katzenellenbogen JA, Katzenellenbogen BS, Foidart JM, Gourdy P, Lenfant F, Arnal JF, Henrion D, Fontaine C.

J Am Heart Assoc. 2018 Jun 29;7(13). pii: e008950. doi: 10.1161/JAHA.118.008950.

8.

Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?

Belizna C, Stojanovich L, Cohen-Tervaert JW, Fassot C, Henrion D, Loufrani L, Nagy G, Muchardt C, Hasan M, Ungeheuer MN, Arnaud L, Alijotas-Reig J, Esteve-Valverde E, Nicoletti F, Saulnier P, Godon A, Reynier P, Chrétien JM, Damian L, Omarjee L, Mahé G, Pistorius MA, Meroni PL, Devreese K.

Autoimmun Rev. 2018 Aug;17(8):739-745. doi: 10.1016/j.autrev.2018.01.027. Epub 2018 Jun 6. Review.

9.

In Utero Exposure to Maternal Diabetes Is Associated With Early Abnormal Vascular Structure in Offspring.

Dib A, Payen C, Bourreau J, Munier M, Grimaud L, Fajloun Z, Loufrani L, Henrion D, Fassot C.

Front Physiol. 2018 Apr 4;9:350. doi: 10.3389/fphys.2018.00350. eCollection 2018.

10.

The endothelial αENaC contributes to vascular endothelial function in vivo.

Tarjus A, Maase M, Jeggle P, Martinez-Martinez E, Fassot C, Loufrani L, Henrion D, Hansen PBL, Kusche-Vihrog K, Jaisser F.

PLoS One. 2017 Sep 26;12(9):e0185319. doi: 10.1371/journal.pone.0185319. eCollection 2017.

11.

Microvascular vasodilator properties of the angiotensin II type 2 receptor in a mouse model of type 1 diabetes.

Begorre MA, Dib A, Habchi K, Guihot AL, Bourreau J, Vessieres E, Blondeau B, Loufrani L, Chabbert M, Henrion D, Fassot C.

Sci Rep. 2017 Mar 31;7:45625. doi: 10.1038/srep45625.

12.

Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model.

Le Page S, Niro M, Fauconnier J, Cellier L, Tamareille S, Gharib A, Chevrollier A, Loufrani L, Grenier C, Kamel R, Sarzi E, Lacampagne A, Ovize M, Henrion D, Reynier P, Lenaers G, Mirebeau-Prunier D, Prunier F.

PLoS One. 2016 Oct 10;11(10):e0164066. doi: 10.1371/journal.pone.0164066. eCollection 2016.

13.

The angiotensin II type 2 receptor activates flow-mediated outward remodelling through T cells-dependent interleukin-17 production.

Caillon A, Grenier C, Grimaud L, Vessieres E, Guihot AL, Blanchard S, Lelievre E, Chabbert M, Foucher ED, Jeannin P, Beauvillain C, Abraham P, Loufrani L, Delneste Y, Henrion D.

Cardiovasc Res. 2016 Oct;112(1):515-25. doi: 10.1093/cvr/cvw172. Epub 2016 Jun 21.

PMID:
27328880
14.

Central Role of P2Y6 UDP Receptor in Arteriolar Myogenic Tone.

Kauffenstein G, Tamareille S, Prunier F, Roy C, Ayer A, Toutain B, Billaud M, Isakson BE, Grimaud L, Loufrani L, Rousseau P, Abraham P, Procaccio V, Monyer H, de Wit C, Boeynaems JM, Robaye B, Kwak BR, Henrion D.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1598-606. doi: 10.1161/ATVBAHA.116.307739. Epub 2016 Jun 2.

15.

Long Lasting Microvascular Tone Alteration in Rat Offspring Exposed In Utero to Maternal Hyperglycaemia.

Vessières E, Dib A, Bourreau J, Lelièvre E, Custaud MA, Lelièvre-Pégorier M, Loufrani L, Henrion D, Fassot C.

PLoS One. 2016 Jan 12;11(1):e0146830. doi: 10.1371/journal.pone.0146830. eCollection 2016.

16.

Resveratrol Improved Flow-Mediated Outward Arterial Remodeling in Ovariectomized Rats with Hypertrophic Effect at High Dose.

Petit M, Guihot AL, Grimaud L, Vessieres E, Toutain B, Menet MC, Nivet-Antoine V, Arnal JF, Loufrani L, Procaccio V, Henrion D.

PLoS One. 2016 Jan 6;11(1):e0146148. doi: 10.1371/journal.pone.0146148. eCollection 2016.

17.

Estrogens are needed for the improvement in endothelium-mediated dilation induced by a chronic increase in blood flow in rat mesenteric arteries.

Tarhouni K, Guihot AL, Vessieres E, Procaccio V, Grimaud L, Abraham P, Lenfant F, Arnal JF, Favre J, Loufrani L, Henrion D.

Vascul Pharmacol. 2016 May;80:35-42. doi: 10.1016/j.vph.2015.10.004. Epub 2015 Oct 22.

PMID:
26471832
18.

Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

Camus SM, De Moraes JA, Bonnin P, Abbyad P, Le Jeune S, Lionnet F, Loufrani L, Grimaud L, Lambry JC, Charue D, Kiger L, Renard JM, Larroque C, Le Clésiau H, Tedgui A, Bruneval P, Barja-Fidalgo C, Alexandrou A, Tharaux PL, Boulanger CM, Blanc-Brude OP.

Blood. 2015 Jun 11;125(24):3805-14. doi: 10.1182/blood-2014-07-589283. Epub 2015 Mar 31.

19.

Smooth muscle specific Rac1 deficiency induces hypertension by preventing p116RIP3-dependent RhoA inhibition.

André G, Sandoval JE, Retailleau K, Loufrani L, Toumaniantz G, Offermanns S, Rolli-Derkinderen M, Loirand G, Sauzeau V.

J Am Heart Assoc. 2014 Jun 17;3(3):e000852. doi: 10.1161/JAHA.114.000852.

20.

Role of estrogens and age in flow-mediated outward remodeling of rat mesenteric resistance arteries.

Tarhouni K, Freidja ML, Guihot AL, Vessieres E, Grimaud L, Toutain B, Lenfant F, Arnal JF, Loufrani L, Henrion D.

Am J Physiol Heart Circ Physiol. 2014 Aug 15;307(4):H504-14.

21.

Time-related alteration in flow- (shear stress-) mediated remodeling in resistance arteries from spontaneously hypertensive rats.

Dumont O, Kauffenstein G, Guihot AL, Guérineau NC, Abraham P, Loufrani L, Henrion D.

Int J Hypertens. 2014;2014:859793. doi: 10.1155/2014/859793. Epub 2014 May 8.

22.

Determinants of flow-mediated outward remodeling in female rodents: respective roles of age, estrogens, and timing.

Tarhouni K, Guihot AL, Vessières E, Toutain B, Procaccio V, Grimaud L, Loufrani L, Lenfant F, Arnal JF, Henrion D.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1281-9. doi: 10.1161/ATVBAHA.114.303404. Epub 2014 Apr 3.

PMID:
24700123
23.

AGEs breaking and antioxidant treatment improves endothelium-dependent dilation without effect on flow-mediated remodeling of resistance arteries in old Zucker diabetic rats.

Freidja ML, Vessières E, Toutain B, Guihot AL, Custaud MA, Loufrani L, Fassot C, Henrion D.

Cardiovasc Diabetol. 2014 Mar 3;13:55. doi: 10.1186/1475-2840-13-55.

24.

Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients.

Schmidt-Tanguy A, Voswinkel J, Henrion D, Subra JF, Loufrani L, Rohmer V, Ifrah N, Belizna C.

J Thromb Haemost. 2013 Oct;11(10):1927-9. doi: 10.1111/jth.12363. No abstract available.

25.

COX-2-derived prostanoids and oxidative stress additionally reduce endothelium-mediated relaxation in old type 2 diabetic rats.

Vessières E, Guihot AL, Toutain B, Maquigneau M, Fassot C, Loufrani L, Henrion D.

PLoS One. 2013 Jul 9;8(7):e68217. doi: 10.1371/journal.pone.0068217. Print 2013.

26.

Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models.

Cristofaro B, Shi Y, Faria M, Suchting S, Leroyer AS, Trindade A, Duarte A, Zovein AC, Iruela-Arispe ML, Nih LR, Kubis N, Henrion D, Loufrani L, Todiras M, Schleifenbaum J, Gollasch M, Zhuang ZW, Simons M, Eichmann A, le Noble F.

Development. 2013 Apr;140(8):1720-9. doi: 10.1242/dev.092304.

27.

Cyclooxygenase-2-derived prostanoids reduce inward arterial remodeling induced by blood flow reduction in old obese Zucker rat mesenteric arteries.

Vessières E, Belin de Chantemèle EJ, Guihot AL, Jardel A, Toutain B, Loufrani L, Henrion D.

Vascul Pharmacol. 2013 May-Jun;58(5-6):356-62. doi: 10.1016/j.vph.2013.03.001. Epub 2013 Mar 21.

PMID:
23524072
28.

Inactivation of serum response factor contributes to decrease vascular muscular tone and arterial stiffness in mice.

Galmiche G, Labat C, Mericskay M, Aissa KA, Blanc J, Retailleau K, Bourhim M, Coletti D, Loufrani L, Gao-Li J, Feil R, Challande P, Henrion D, Decaux JF, Regnault V, Lacolley P, Li Z.

Circ Res. 2013 Mar 29;112(7):1035-45. doi: 10.1161/CIRCRESAHA.113.301076. Epub 2013 Feb 20.

PMID:
23426017
29.

Key role of estrogens and endothelial estrogen receptor α in blood flow-mediated remodeling of resistance arteries.

Tarhouni K, Guihot AL, Freidja ML, Toutain B, Henrion B, Baufreton C, Pinaud F, Procaccio V, Grimaud L, Ayer A, Loufrani L, Lenfant F, Arnal JF, Henrion D.

Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):605-11. doi: 10.1161/ATVBAHA.112.300334. Epub 2013 Jan 3.

PMID:
23288162
30.

Selective involvement of serum response factor in pressure-induced myogenic tone in resistance arteries.

Retailleau K, Toutain B, Galmiche G, Fassot C, Sharif-Naeini R, Kauffenstein G, Mericskay M, Duprat F, Grimaud L, Merot J, Lardeux A, Pizard A, Baudrie V, Jeunemaitre X, Feil R, Göthert JR, Lacolley P, Henrion D, Li Z, Loufrani L.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):339-46. doi: 10.1161/ATVBAHA.112.300708. Epub 2012 Dec 20.

PMID:
23264443
31.

Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease.

Camus SM, Gausserès B, Bonnin P, Loufrani L, Grimaud L, Charue D, De Moraes JA, Renard JM, Tedgui A, Boulanger CM, Tharaux PL, Blanc-Brude OP.

Blood. 2012 Dec 13;120(25):5050-8. doi: 10.1182/blood-2012-02-413138. Epub 2012 Sep 13.

PMID:
22976952
32.

Flow (shear stress)-mediated remodeling of resistance arteries in diabetes.

Vessières E, Freidja ML, Loufrani L, Fassot C, Henrion D.

Vascul Pharmacol. 2012 Nov-Dec;57(5-6):173-8. doi: 10.1016/j.vph.2012.03.006. Epub 2012 Mar 29. Review.

33.

The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes.

Freidja ML, Tarhouni K, Toutain B, Fassot C, Loufrani L, Henrion D.

Diabetes. 2012 Jun;61(6):1562-72. doi: 10.2337/db11-0750. Epub 2012 Mar 13.

34.

Arterial stiffness and stroke in sickle cell disease.

Belizna C, Loufrani L, Ghali A, Lahary A, Primard E, Louvel JP, Henrion D, Lévesque H, Ifrah N.

Stroke. 2012 Apr;43(4):1129-30. doi: 10.1161/STROKEAHA.111.635383. Epub 2011 Dec 22.

PMID:
22198986
35.

In vitro protection of vascular function from oxidative stress and inflammation by pulsatility in resistance arteries.

Pinaud F, Loufrani L, Toutain B, Lambert D, Vandekerckhove L, Henrion D, Baufreton C.

J Thorac Cardiovasc Surg. 2011 Nov;142(5):1254-62. doi: 10.1016/j.jtcvs.2011.07.007. Epub 2011 Aug 16.

36.

Heme oxygenase 1 is differentially involved in blood flow-dependent arterial remodeling: role of inflammation, oxidative stress, and nitric oxide.

Freidja ML, Toutain B, Caillon A, Desquiret V, Lambert D, Loufrani L, Procaccio V, Henrion D.

Hypertension. 2011 Aug;58(2):225-31. doi: 10.1161/HYPERTENSIONAHA.111.170266. Epub 2011 Jun 20.

PMID:
21690482
37.

A 5-year prospective follow-up study in essential cryofibrinogenemia patients.

Belizna C, Loufrani L, Subra JF, Godin M, Jolly P, Vitecocq O, Faller B, Ghali A, Tron F, Hamidou M, Henrion D, Lévesque H, Ifrah N.

Autoimmun Rev. 2011 Jul;10(9):559-62. doi: 10.1016/j.autrev.2011.04.009. Epub 2011 Apr 27.

PMID:
21549859
38.

Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.

Ghaboura N, Tamareille S, Ducluzeau PH, Grimaud L, Loufrani L, Croué A, Tourmen Y, Henrion D, Furber A, Prunier F.

Basic Res Cardiol. 2011 Jan;106(1):147-62. doi: 10.1007/s00395-010-0130-3. Epub 2010 Oct 28.

PMID:
20981553
39.

Heme oxygenase-1 induction restores high-blood-flow-dependent remodeling and endothelial function in mesenteric arteries of old rats.

Freidja ML, Vessieres E, Clere N, Desquiret V, Guihot AL, Toutain B, Loufrani L, Jardel A, Procaccio V, Faure S, Henrion D.

J Hypertens. 2011 Jan;29(1):102-12. doi: 10.1097/HJH.0b013e32833db36e.

PMID:
20935577
40.

Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats.

Ganster F, Burban M, de la Bourdonnaye M, Fizanne L, Douay O, Loufrani L, Mercat A, Calès P, Radermacher P, Henrion D, Asfar P, Meziani F.

Crit Care. 2010;14(5):R165. doi: 10.1186/cc9257. Epub 2010 Sep 13.

41.

Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.

Baron-Menguy C, Toutain B, Cousin M, Dumont O, Guihot AL, Vessières E, Subra JF, Custaud MA, Loufrani L, Henrion D.

Hypertens Res. 2010 Aug;33(8):857-66. doi: 10.1038/hr.2010.83. Epub 2010 Jun 10.

PMID:
20535114
42.

Pulsatile shear and Gja5 modulate arterial identity and remodeling events during flow-driven arteriogenesis.

Buschmann I, Pries A, Styp-Rekowska B, Hillmeister P, Loufrani L, Henrion D, Shi Y, Duelsner A, Hoefer I, Gatzke N, Wang H, Lehmann K, Ulm L, Ritter Z, Hauff P, Hlushchuk R, Djonov V, van Veen T, le Noble F.

Development. 2010 Jul;137(13):2187-96. doi: 10.1242/dev.045351.

43.

The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure.

Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, Labat C, Benjamin L, Farman N, Lacolley P, Henrion D, Jaisser F.

FASEB J. 2010 Jul;24(7):2454-63. doi: 10.1096/fj.09-147926. Epub 2010 Mar 18.

PMID:
20299606
44.

The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.

Guilluy C, Brégeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L, Henrion D, Scalbert E, Bril A, Torres RM, Offermanns S, Pacaud P, Loirand G.

Nat Med. 2010 Feb;16(2):183-90. doi: 10.1038/nm.2079. Epub 2010 Jan 24.

PMID:
20098430
45.

Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese zucker rat mesenteric arteries.

Vessières E, Belin de Chantemèle EJ, Toutain B, Guihot AL, Jardel A, Loufrani L, Henrion D.

Front Physiol. 2010 Nov 2;1:145. doi: 10.3389/fphys.2010.00145. eCollection 2010.

46.

Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries.

Belin de Chantemèle EJ, Vessières E, Guihot AL, Toutain B, Loufrani L, Henrion D.

Cardiovasc Res. 2010 Jun 1;86(3):516-25. doi: 10.1093/cvr/cvp411. Epub 2009 Dec 23.

PMID:
20032084
47.

Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries.

Retailleau K, Belin de Chantemèle EJ, Chanoine S, Guihot AL, Vessières E, Toutain B, Faure S, Bagi Z, Loufrani L, Henrion D.

Hypertension. 2010 Feb;55(2):339-44. doi: 10.1161/HYPERTENSIONAHA.109.140236. Epub 2009 Dec 21.

PMID:
20026767
48.

Dihydrochalcones: Implication in resistance to oxidative stress and bioactivities against advanced glycation end-products and vasoconstriction.

Dugé de Bernonville T, Guyot S, Paulin JP, Gaucher M, Loufrani L, Henrion D, Derbré S, Guilet D, Richomme P, Dat JF, Brisset MN.

Phytochemistry. 2010 Mar;71(4):443-52. doi: 10.1016/j.phytochem.2009.11.004. Epub 2009 Dec 21.

PMID:
20022617
49.

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

Koïtka A, Cao Z, Koh P, Watson AM, Sourris KC, Loufrani L, Soro-Paavonen A, Walther T, Woollard KJ, Jandeleit-Dahm KA, Cooper ME, Allen TJ.

Diabetologia. 2010 Mar;53(3):584-92. doi: 10.1007/s00125-009-1619-x. Epub 2009 Dec 3.

PMID:
19957160
50.

Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.

Cousin M, Custaud MA, Baron-Menguy C, Toutain B, Dumont O, Guihot AL, Vessières E, Subra JF, Henrion D, Loufrani L.

Hypertension. 2010 Jan;55(1):109-15. doi: 10.1161/HYPERTENSIONAHA.108.127456. Epub 2009 Nov 30.

PMID:
19948989

Supplemental Content

Loading ...
Support Center